Investing
Cathie Wood's ARK Invest Sells Over 230,000 Shares of Pfizer
November 10, 2021 7:45 am
One ARK Invest exchange-traded fund run by ETF star Cathie Wood sold over 230,000 shares of Pfizer Inc. (NYSE: PFE) on Tuesday, as the price of this fund pulled back over 2% in the day’s session. However, it is up a fair amount in the past year.
ARK Genomic Revolution ETF (NYSEARCA: ARKG) parted with 238,235 shares of Pfizer. At Tuesday’s closing price, this would have valued this sale at roughly $11.3 million. This is only a small fraction of the total holdings. The fund is up about 10% over the past 52 weeks.
Check out all the ARK Invest buys for Tuesday:
| Fund | Ticker | Name | Shares |
|---|---|---|---|
| ARKG | REGN | REGENERON PHARMACEUTICALS | 17,447 |
| ARKG | PFE | PFIZER | 238,235 |
| ARKG | CSTL | CASTLE BIOSCIENCES | 200 |
| ARKG | CLLS | CELLECTIS | 25,000 |
| ARKK | PRLB | PROTO LABS | 23,707 |
| ARKK | U | UNITY SOFTWARE | 121,968 |
| ARKQ | U | UNITY SOFTWARE | 47,465 |
| ARKW | RBLX | ROBLOX | 82,267 |
| ARKW | U | UNITY SOFTWARE | 33,281 |
| ARKX | U | UNITY SOFTWARE | 5,343 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of 247wallst.com.
24/7 Wall St.Sponsored: Tips for Investing
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
Editors' Picks
